Evercore Partners Inc. (NYSE:EVR) today announced that its U.S. GAAP Net
Revenues were $227.2 million for the quarter ended September 30, 2014,
compared to $187.3 million and $217.7 million for the quarters ended
September 30, 2013 and June 30, 2014, respectively.
Third-Quarter 2014 Financial Highlights - Third-quarter revenues of $27.6 million, up 14.3% year-over-year; year-to-date revenue up by 57.9% - Quarterly Gross Margin at 39.4%, as compared to 39.5% year over year, and 37.8% quarter over quarter
- Quarterly Non-GAAP net income of $3.5 million, up 75.4% year over year - Non-GAAP diluted EPS at $0.12 per ADS reported for the quarter, up 100% year over year -Year-to-date Non-GAAP net income of $3.0 million, non-GAAP diluted EPS at $0.11 per ADS BEIJING , Nov.
Sallie Mae (NASDAQ: SLM), formally SLM Corporation, today released
third-quarter 2014 financial results that reflected increases in private
education loan originations, portfolio size and net interest income.
DCT Industrial Trust ® (NYSE: DCT), a leading industrial real
estate company, today announced it will release financial results for
the third quarter ending September 30, 2014 after the market closes on
Thursday, October 30, 2014.
(Nasdaq: PTC) today announced that preliminary revenue for the fourth
fiscal quarter ended September 30, 2014 is expected to be at or above
the high end of the company's guidance of $340 million to $355 million,
before considering the acquisition of Axeda, which closed August 11.
Concurrent, (NASDAQ:CCUR), a global leader in unified content delivery
and video analytics solutions, today unveiled support for new
high-density edge server configurations in its latest UpShift content
delivery network software release.
Sign-up for SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against 21Vianet Group, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 11, 2014 -- VNET investment picks
OvaScience SM (NASDAQ:OVAS), a global life sciences company
focused on the discovery, development and commercialization of new
fertility treatments, today reported third quarter 2014 financial
Sign-up for AUXILIUM PHARMACEUTICALS INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Auxilium Pharmaceuticals Inc. (AUXL) over the Proposed Sale of the Company to Endo International PLC (ENDP) investment picks
NEW YORK, NEW YORK --
Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical
company focused on developing and commercializing first-in-class, oral
low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies
for the treatment of hypercholesterolemia and other cardiometabolic risk
markers, today provided ETC-1002 development program updates and
financial results for the third quarter ended September 30, 2014.
As carriers like Verizon Wireless (VZ) , T-Mobile (TMUS) and AT&T (T) ditch traditional two-year contracts, they are making it easier for consumers to upgrade to newer phones, Citigroup said Thursday in a note to clients.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.